World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
109
Citations
47483
World Ranking
5743
National Ranking
320

Overview

Eckhard Thiel is primarily affiliated with Charité - University Medicine Berlin in Germany. Their research is predominantly situated within the field of Medicine, with a particular focus on Oncology, Epidemiology, Hematology, Pulmonary and Respiratory Medicine, and Infectious Diseases.

The scientist has contributed to several topics, particularly in areas concerning neutropenia and cancer infections, Pneumocystis jirovecii pneumonia detection and treatment, lymphoma diagnosis and treatment, antifungal resistance and susceptibility, fungal infections and studies, acute myeloid leukemia research, and chronic lymphocytic leukemia research.

Prominent recent papers authored by or involving Eckhard Thiel include:

  • "Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial" (2020, The Lancet. Gastroenterology & Hepatology)
  • "Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry" (2020, Journal of Cancer Research and Clinical Oncology)
  • "Prophylaxis, diagnosis and therapy of infections in patients undergoing high-dose chemotherapy and autologous haematopoietic stem cell transplantation. 2020 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)" (2020, Annals of Hematology)
  • "Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO/DGHO)" (2021, Annals of Hematology)
  • "Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)" (2023, Journal of Antimicrobial Chemotherapy)

Eckhard Thiel frequently collaborates with several researchers, including:

  • Andreas Hochhaus (6 publications)
  • Christoph Kahl (5 publications)
  • Olaf Penack (5 publications)
  • Martin Schmidt-Hieber (5 publications)
  • Oliver A. Cornely (5 publications)

The scientist frequently publishes in several venues, including:

  • Annals of Hematology (8 publications)
  • Oncology Research and Treatment (6 publications)
  • Leukemia (3 publications)
  • European Journal of Cancer (2 publications)
  • InFo Hämatologie + Onkologie (2 publications)

Best Publications

  • Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis

    Raoul Herbrecht;David W. Denning;David W. Denning;Thomas F. Patterson;John E. Bennett

  • Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation

    Gero Hütter;Daniel Nowak;Maximilian Mossner;Susanne Ganepola

  • Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive Aspergillosis

    David W. Denning;Patricia Ribaud;Noel Milpied;Denis Caillot

  • Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation.

    Kristina Allers;Gero Hütter;Jörg Hofmann;Christoph Loddenkemper

  • Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma

    Lauren E. Abrey;Tracy T. Batchelor;Andrés J.M. Ferreri;Mary Gospodarowicz

  • Establishment of a human cell line (mono mac 6) with characteristics of mature monocytes

    H. W. Löms Ziegler-Heitbroc;Eckhard Thiel;Agnes Futterer;Volker Herzog

  • Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults

    D Hoelzer;E Thiel;H Loffler;T Buchner

  • High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial

    Eckhard Thiel;Agnieszka Korfel;Peter Martus;Lothar Kanz

  • Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia.

    Monika Brüggemann;Thorsten Raff;Thomas Flohr;Nicola Gökbuget

  • Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies.

    Nicola Gökbuget;Michael Kneba;Thorsten Raff;Heiko Trautmann

  • Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients

    Wilhelm Küker;Thomas Nägele;Agnieska Korfel;Stefan Heckl

  • Improved outcome in central nervous system aspergillosis, using voriconazole treatment.

    Stefan Schwartz;Markus Ruhnke;Patricia Ribaud;Lawrence Corey

  • Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis

    Beate Gleißner;Nicola Gökbuget;Claus R. Bartram;Bart Janssen

  • Intensified therapy in acute lymphoblastic and acute undifferentiated leukemia in adults.

    D Hoelzer;E Thiel;H Loffler;H Bodenstein

  • Improved outcome in adult B-cell acute lymphoblastic leukemia

    D Hoelzer;W D Ludwig;E Thiel;W Gassmann

  • A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS.

    Ulrich Keilholz;Anne Letsch;Antonia Busse;Anne Marie Asemissen

  • Presence of Wilms' Tumor Gene (wt1) Transcripts and the WT1 Nuclear Protein in the Majority of Human Acute Leukemias

    Menssen Hd;Renkl Hj;Rodeck U;Maurer J

  • Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction.

    J. Maurer;E. Thiel;W.-D. Ludwig;J.W.G. Janssen

  • Intestinal Non-Hodgkin’s Lymphoma: A Multicenter Prospective Clinical Study From the German Study Group on Intestinal Non-Hodgkin’s Lymphoma

    Severin Daum;Reiner Ullrich;Walter Heise;Bettina Dederke

  • Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia.

    Michael Hallek;Irmgard Langenmayer;Christoph Nerl;Wolfgang Knauf

Frequent Co-Authors

Ulrich Keilholz
Ulrich Keilholz Charité - University Medicine Berlin
Dieter Hoelzer
Dieter Hoelzer Goethe University Frankfurt
Carmen Scheibenbogen
Carmen Scheibenbogen Charité - University Medicine Berlin
Peter Martus
Peter Martus University of Tübingen
Michael Weller
Michael Weller University of Zurich
Christoph Loddenkemper
Christoph Loddenkemper Charité - University Medicine Berlin
Wolfgang E. Berdel
Wolfgang E. Berdel University of Münster
Harald Stein
Harald Stein Charité - University Medicine Berlin
Hubert Serve
Hubert Serve Goethe University Frankfurt
Richard Reinhardt
Richard Reinhardt Max Planck Society

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in medicine doesn’t always require a traditional MD path. Today, there are several cahme accredited mha online programs for those interested in healthcare administration. These programs offer flexibility and a strong reputation for quality, making them ideal for future healthcare leaders.

For registered nurses eager to advance, many universities now offer rn to bsn programs without clinicals. These degrees streamline the process, removing the need for additional hands-on requirements for experienced professionals.

Those seeking the highest clinical degree in nursing can consider the fastest online dnp programs. These programs help advanced practice nurses reach their goals more quickly while maintaining high academic standards.

Cost is a common concern for many students, making cheapest dnp program options especially attractive. These affordable online degrees provide paths to top clinical and leadership roles in healthcare. Whether you focus on management, hands-on care, or research, online learning can create new opportunities in the U.S. medical field.

Best Scientists Citing Eckhard Thiel

Trending Scientists

Recently Published Articles